Advanced Malignant Solid Tumor Clinical Trial
Official title:
A Phase I Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of The Anti-CLDN18.2 and CD47 Bispecific Antibody AK132 in Advanced Malignant Solid Tumor
This is A Phase I Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of The anti-CLDN18.2 and CD47 Bispecific Antibody AK132 in Advanced Malignant Solid Tumor
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04864379 -
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04165590 -
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT05098405 -
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06150183 -
Safety and Preliminary Efficacy of BNT314 With or Without an Immune Checkpoint Inhibitor in Cancer Patients With Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05911984 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05396339 -
A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03171220 -
Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04241835 -
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
|
Phase 1 | |
| Active, not recruiting |
NCT03662815 -
Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor
|
Phase 1 | |
| Recruiting |
NCT05477849 -
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients With Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT04275050 -
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
|
Phase 1 | |
| Recruiting |
NCT04758897 -
Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors
|
Phase 1 |